Intuitive Surgical stock holds steady. Focus stays on procedures.

Intuitive Surgical stock remains tied to procedure growth and system utilization as the company continues to report through its own investor channels. The shares trade on Nasdaq and remain a U.S. large-cap healthcare name.

By Julia Smith, Sector & Peers desk. Reviewed on July 5, 2026 at 6:57 p.m. ET.

Intuitive Surgical, Inc. (ISIN US46120E6023) remains a closely watched U.S. healthcare stock because its business is tied to robotic-assisted procedure volume, instrument use and installed-system activity. The company trades on Nasdaq and reports through its own investor relations channel.

Business model

The core story is still the same: Intuitive Surgical sells robotic systems and then earns recurring revenue from instruments, accessories and services as procedures build over time. That mix gives investors a clear lens on utilization, system placements and long-term procedure growth.

Market frame

With no fresh public catalyst available in the current source set, the stock can be framed through its operating model and its position in U.S. healthcare. That keeps the focus on the company's procedure-driven economics rather than short-term noise.

Robotic surgery platform

da Vinci remains the company's signature platform and the best-known example of its product-led model. The system sits at the center of the recurring revenue engine because procedure activity drives instrument consumption and service demand.

Shares and valuation

Intuitive Surgical shares are listed on Nasdaq and priced in U.S. dollars, with the latest available market context centered on the company's operating profile rather than a new headline catalyst. As of July 5, 2026, the stock price was not included in the available source set.

Fact box

• Company: Intuitive Surgical, Inc.
• ISIN: US46120E6023
• Ticker: ISRG
• Exchange: Nasdaq
• Sector / Industry: Health Care / Health Care Equipment
• Index membership: S&P 500
• Next earnings date: not yet officially scheduled

This article was generated automatically and technically reviewed before publication. Market prices, analyst data and company information are provided without warranty and may change at short notice. This content is for informational purposes only and is not investment, financial, legal or tax advice. It is not a recommendation to buy or sell any security. Investing in securities involves risk, including the possible loss of principal.